{
  "main_header": {
    "sid": 515837,
    "name": "Vivanza Biosci.",
    "stock_name": "Vivanza Biosci.",
    "full_name": "Vivanza Biosciences Ltd",
    "name_url": "stocks-analysis/vivanza-biosci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1.88",
    "chg": -0.01,
    "chgp": "-0.53%",
    "dir": -1,
    "prev_price": "1.89",
    "mcapval": "8.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530057,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 67,
    "indexname": "India SENSEX",
    "isin": "INE984E01035",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "7.91 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/vivanza-biosci-515837-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vivanza Biosciences Downgraded to Strong Sell Amid Technical and Fundamental Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivanza-biosciences-downgraded-to-strong-sell-amid-technical-and-fundamental-weakness-3998309",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/VivanzaBioscien_mojoScore_3998309.png",
        "date": "2026-05-19 08:30:38",
        "description": "Vivanza Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 May 2026. This revision reflects deteriorating technical indicators, persistent operating losses, and weak long-term fundamentals despite recent positive quarterly financial results."
      }
    ],
    "total": 15,
    "sid": "515837",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/vivanza-biosciences-515837"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "08-Aug-2026",
      "details": "in the terms of Regulation 47 of the SEBI(LODR) Regulation 2015 Please find the copy of the Newspaper in the English and vernacular Language of the State wherein the Unaudited Standalone and Consolidated Financial Statements for the Quarter Ended on June 30 2026 Published.",
      "source": "BSE"
    },
    {
      "caption": "Non Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI LODR Regulations 2015",
      "datetime": "08-Aug-2026",
      "details": "Pursuant to Regulation 32 of the SEBI(LODR) Regulation 2015 Read with SEBI circular dated 24th December 2019 regarding the submission of the statement of deviation or variation from the proceeds of public issue/rights issue/preferential issue qualified institutional placement etc. we hereby confirm that the company has not raised any further funds by means of Public Issue rights issue or preferential issue etc. hence the statement of deviation and variation is not applicable to the company.",
      "source": "BSE"
    },
    {
      "caption": "Outcome Of Board Of Directors Meeting Of Vivanza Biosciences Limited (The Company)",
      "datetime": "07-Aug-2026",
      "details": "Approval of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30th June 2026 and other items .",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Vivanza Biosciences Ltd has announced <strong>1:10</strong> stock split, ex-date: 24 Mar 23",
          "dt": "2023-03-24",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Vivanza Biosciences Downgraded to Strong Sell Amid Technical and Fundamental Weakness

2026-05-19 08:30:38

Vivanza Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Sell to Strong Sell as of 18 May 2026. This revision reflects deteriorating technical indicators, persistent operating losses, and weak long-term fundamentals despite recent positive quarterly financial results.

Read More

View All News